Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Not yet recruiting 2Terminated 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 3092Neoplasms 2436Carcinoma, Non-Small-Cell Lung 1863Prostatic Neoplasms 1617Colorectal Neoplasms 1422Lung Neoplasms 1292Multiple Myeloma 927Neoplasm Metastasis 919Leukemia, Myeloid, Acute 874Pancreatic Neoplasms 847Ovarian Neoplasms 799Melanoma 783Carcinoma, Hepatocellular 736Stomach Neoplasms 639Brain Neoplasms 635Recurrence 633Squamous Cell Carcinoma of Head and Neck 630Head and Neck Neoplasms 609Glioblastoma 566Lymphoma 539Uterine Cervical Neoplasms 537Triple Negative Breast Neoplasms 504Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Carcinoma, Renal Cell 497Hematologic Neoplasms 462Urinary Bladder Neoplasms 459Endometrial Neoplasms 459Colonic Neoplasms 441Lymphoma, Non-Hodgkin 435Sarcoma 434

Interventions

Sevoflurane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Chalazion × 1 year × Clear all
NCT07496515 2026-03-27

CH01

Jaeb Center for Health Research

Phase 2 Not yet recruiting
168 enrolled

Chalazion

NCT07450495 2026-03-04

SEVO-PED

Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong

Phase NA Recruiting
80 enrolled

Chalazion

NCT07405138 2026-02-19

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

Lumenis Be Ltd.

Phase NA Not yet recruiting
40 enrolled

Chalazion

NCT07039461 2026-01-06

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

Lumenis Be Ltd.

Phase NA Terminated
4 enrolled

Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡